This study tested a new vaccine called EO2401 in 100 adults with glioblastoma that had returned after standard treatment. The vaccine was given alone or with other drugs to see if it is safe and helps the immune system fight the cancer. The goal was to find a better way to contro…
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:51 UTC